Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence.

[1]  P. Salovey,et al.  Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: a randomized controlled trial. , 2007, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

[2]  T. Ishibashi,et al.  Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. , 2007, Clinical therapeutics.

[3]  Hong-Jun Cho,et al.  A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers. , 2007, Clinical therapeutics.

[4]  C. Billing,et al.  A double-blind study evaluating the long-term safety of varenicline for smoking cessation* , 2007, Current medical research and opinion.

[5]  R. Anziano,et al.  Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. , 2006, Archives of internal medicine.

[6]  R. Anziano,et al.  Long-term fatty fish consumption and renal cell carcinoma incidence in women. , 2006, JAMA.

[7]  Jason Gong,et al.  Efficacy of Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation A Randomized Controlled Trial , 2006 .

[8]  David Gonzales,et al.  Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial , 2006 .

[9]  S. Tonstad,et al.  Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. , 2006, JAMA.

[10]  R. Makuch,et al.  A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation. , 2006, Archives of internal medicine.

[11]  D. Hedeker,et al.  Randomized controlled trial for behavioral smoking and weight control treatment: effect of concurrent versus sequential intervention. , 2004, Journal of consulting and clinical psychology.

[12]  F. Lebargy,et al.  Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial. , 2004, Addiction.

[13]  G. Gmel,et al.  Measuring Alcohol Consumption , 2004 .

[14]  A. Buist,et al.  Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression , 2004, Journal of General Internal Medicine.

[15]  A. Breland,et al.  Urine cotinine as an index of smoking status in smokers during 96-hr abstinence: comparison between gas chromatography/mass spectrometry and immunoassay test strips. , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[16]  J. Vestbo,et al.  A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees. , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[17]  S. Tonstad,et al.  A multicentre, randomized, double‐blind, placebo‐controlled, 1‐year study of bupropion SR for smoking cessation , 2003, Journal of internal medicine.

[18]  S. Tonstad,et al.  Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. , 2003, European heart journal.

[19]  S. Hall,et al.  Psychological intervention and antidepressant treatment in smoking cessation. , 2002, Archives of general psychiatry.

[20]  M. Mayo,et al.  Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial. , 2002, JAMA.

[21]  S. Shiffman,et al.  Efficacy of a nicotine lozenge for smoking cessation. , 2002, Archives of internal medicine.

[22]  W. Velicer,et al.  Biochemical verification of tobacco use and cessation. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[23]  A. Buist,et al.  Sustained-Release Bupropion for Pharmacologic Relapse Prevention after Smoking Cessation , 2001, Annals of Internal Medicine.

[24]  B. Jamerson,et al.  Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: A randomized placebo‐controlled study , 2001, Clinical pharmacology and therapeutics.

[25]  P. Anderson,et al.  Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial , 2001, The Lancet.

[26]  Patricia Dolan Mullen,et al.  Treating tobacco use and dependence: clinical practice guideline , 2000 .

[27]  A. Morice,et al.  Breath carbon monoxide as an indication of smoking habit. , 2000, Chest.

[28]  D. Schroeder,et al.  Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials. , 1999, American journal of public health.

[29]  J. P. Mckenna,et al.  Are higher doses of nicotine replacement more effective for smoking cessation? , 1999, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[30]  Aker,et al.  A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. , 1999, The New England journal of medicine.

[31]  Richard A. Brown,et al.  Reliability and validity of a smoking timeline follow-back interview. , 1998 .

[32]  J. Connett,et al.  Error in smoking measures: effects of intervention on relations of cotinine and carbon monoxide to self-reported smoking. The Lung Health Study Research Group. , 1993, American journal of public health.

[33]  M. Hariharan,et al.  A high-performance liquid-chromatographic method for routine simultaneous determination of nicotine and cotinine in plasma. , 1988, Clinical chemistry.

[34]  N. Wald,et al.  Placebo controlled trial of nicotine chewing gum in general practice. , 1984, British medical journal.

[35]  G. Swan.  The need for dissemination of evidence-based results from research on nicotine and tobacco. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[36]  Josue P. Keely,et al.  Measures of abstinence in clinical trials: issues and recommendations. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[37]  R. Ehrman,et al.  Detecting smoking following smoking cessation treatment. , 2002, Drug and alcohol dependence.

[38]  D. Schroeder,et al.  A comparison of sustained-release bupropion and placebo for smoking cessation. , 1997, The New England journal of medicine.

[39]  F. Rotgers,et al.  Assessing Alcohol Problems: A Guide for Clinicians and Researchers , 1997 .

[40]  A. Copeland,et al.  Programmed therapeutic messages as a smoking treatment adjunct: reducing the impact of negative affect. , 1995, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[41]  Linda C. Sobell,et al.  Alcohol Consumption Measures , 1995 .

[42]  Linda C. Sobell,et al.  Timeline Follow-Back A Technique for Assessing Self-Reported Alcohol Consumption , 1992 .